Onesource Specialty Pharma (ONESOURCE.NS) Earnings Analysis

Onesource Specialty Pharma (ONESOURCE.NS) next reports earnings on 2026-07-24, consensus EPS 5.3 INR. Last quarter (2026-01-23) it missed with EPS -7.1 INR vs 2 INR est (-455%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E -257.84.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ONESOURCE.NS next report earnings?

Next earnings date2026-07-24
Consensus EPS estimate5.3 INR
Revenue estimate5.03B

ONESOURCE.NS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-01-23-7.1 INR2 INR-455%Miss

Beat rate: 0/1 (0%) over reported quarters with consensus data.

ONESOURCE.NS valuation and analyst view

Trailing P/E-257.84
Trailing EPS-6.42184 INR
Price / book3.27
Dividend yield0.00%
Market cap191.63B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Onesource Specialty Pharma (ONESOURCE.NS)'s next earnings date?

Onesource Specialty Pharma is next scheduled to report on 2026-07-24, with a consensus EPS estimate of 5.3 INR and revenue estimate of 5.03B.

Did ONESOURCE.NS beat earnings last quarter?

In its 2026-01-23 report, ONESOURCE.NS posted EPS of -7.1 INR versus a 2 INR estimate — a miss of 455%.

What is ONESOURCE.NS's earnings track record?

Over the last 1 reported quarters with consensus data, ONESOURCE.NS beat estimates 0 times (0%).

What is ONESOURCE.NS's current P/E ratio and EPS?

ONESOURCE.NS trades at a trailing P/E of -257.84 on trailing EPS of -6.421840330650424 INR.

What do analysts rate ONESOURCE.NS?

ONESOURCE.NS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.